Environment-Sensitive Near-Infrared Probe for Fluorescent Discrimination of Aβ and Tau Fibrils in AD Brain.
Kaixiang ZhouChang YuanBin DaiKan WangYimin ChenDenglei MaJia-Pei DaiYi LiangHongwei TanMeng-Chao CuiPublished in: Journal of medicinal chemistry (2019)
The early noninvasive diagnosis of Alzheimer's disease targeted β-amyloid (Aβ) plaques or Tau tangles is a major challenge because of the coshared β-sheet structure of the target. In contrast to tailoring probes to specific amyloids, here, we showed that near-infrared (NIR) environment-sensitive probe 18 could fluorescently discriminate Aβ and Tau from artificial aggregates to pathological change in the brain tissue. The biological evaluation demonstrated that the substantial fluorescence enhancement, large blueshift in the emission upon interactions with the aggregates, and the high binding affinity significantly contributed to the fluorescent discrimination. A simplified Ooshika-Lippert-Mataga equation provided an effective means of correlating 18 with the static relative permittivity (ε0) of proteins, elucidating the origin of the distinction capabilities, and quantitatively estimating the dielectric properties of proteins. Moreover, 18 possessed high bioavailability, including sufficient blood-brain barrier penetration, in vivo NIR imaging, and ex vivo histology in living mice.
Keyphrases
- living cells
- fluorescent probe
- blood brain barrier
- cerebral ischemia
- quantum dots
- single molecule
- cerebrospinal fluid
- fluorescence imaging
- resting state
- white matter
- photodynamic therapy
- magnetic resonance
- high resolution
- functional connectivity
- drug release
- energy transfer
- small molecule
- magnetic resonance imaging
- computed tomography
- type diabetes
- contrast enhanced
- transcription factor
- insulin resistance
- label free
- metabolic syndrome
- multiple sclerosis
- wild type